Antibody-based immunotherapies can target disease with high precision — but #AntibodyDiscovery workflows are slow & costly. Using streamlined functional analysis earlier in the discovery process can help deliver promising therapies quicker, writes our own Jonathan Didier. go.lightcast.bio/47R6ZoF

Show Post

“Phenotype tells you what a cell is — but 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻 tells you if it has 𝗿𝗲𝗮𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹.” 💡 In this video, Lightcast Assoc. Dir. of Commercial Development Carrie Maynard explains why functional assays are so important for driving innovation in #DrugDiscovery. #ScienceSky #SingleCell

Show Post

From load to dispense in under 6 hours? Paul Wylie, Lightcast Dir. of Portfolio Management, walks through some of the Envisia #microfluidic platform's key features (like speed!), live from our booth at #PEGS2025. Learn more about Envisia: go.lightcast.bio/42ZdDGx www.youtube.com/watch?v=GjEW...

Show Post

Last week at #PEGSummit, we were delighted to reveal our Envisia platform to a global audience — and even more thrilled by the interest and engagement we received. Watch the video to see Envisia in action & hear about Lightcast's plans for the future of #SingleCell. www.youtube.com/watch?v=pePx...

Show Post

Centrally located among biotechs and universities in Kendall Square, our Boston Innovation Center (BIC) manages feasibility studies for our North American customers. 📹 Meet BIC Head Megan Gottlieb and Product Applications Scientist Jassmine Ibea. #ScienceSky 🧪 www.youtube.com/watch?v=57JW...

Show Post